Spittin facts......

First 15513 Last

Share
Profile

Follow
mrdingo

4,481 Posts.

1272

12/09/24

18:31

Post #: 75650612
Share

Originally posted by fourdollars: ↑

I know you're after a serious poster, but you might have to settle for me.

The HER-Vaxx stage 2 trial was never completed, and the data that it did produce did not provide statistical evidence of extended overall survival vs the standard of care.

Instead of completing the trial, IMU announced 3 separate combination trials. The industry was so unimpressed with what IMU had to offer that IMU couldn't even secure free product from companies with which they proposed to run combinations. Let that sink in. IMU was prepared to pay for the clinical trials, but no one would give them free product to combine with HER-Vaxx - even though a successful combination trial would have increased the market for the combination product. Leslie had claimed that IMU was getting free product from Merck, but had to embarrassingly rectify the announcement as the ASX decided what she had announced "needed clarification" (IMO, because Leslie's announcement was B/S).

Of the three new combination trials, one was stopped after a handful of patients were recruited, two never got off the ground.

Everyone should know by now that there is no value in announcements made by Paul and Leslie. Posts get moderated if anyone straight out calls them liars, so I wont.

There is absolutely no point in quoting material released by IMU as evidence of success. Around the HER-Vaxx results time, a series of articles were published in the Financial Review, effectively calling out IMU as a meme stock. They turned out to be prescient.

IMO, IMU created a myth around HER-Vaxx ("three combination trials!", "a special BP liaison to progress a trade sale!" etc ...) so that Paul could offload some shares and IMU could raise capital to progress other initiatives before the truth about HER-Vaxx became apparent.

Expand

Spittin facts......

Last edited by mrdingo: 12/09/24

IMU Price at posting: 5.1¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%